ZGNX
Price:
$26.68
Market Cap:
$0
Zogenix, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapies for rare diseases within the United States, striving to profoundly improve the quality of life for affected patients and their families. Their flagship product candidate, Fintepla, a low-dose fenfluramine, is currently undergoing Phase III clinical evaluation for the management of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome. Additionally, Fintepla is progressing through Phase II trials to address other less common epileptic syndromes and disorders. Another key pipeline asset is MT1621, an investigational treatment targeting thymidine kinase 2 defic...[Read more]
Industry
Biotechnology
IPO Date
2010-11-23
Stock Exchange
NASDAQ
Ticker
ZGNX
According to Zogenix, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 67.30M. This represents a change of -93.34% compared to the average of 1.01B of the last 4 quarters.
The mean historical Enterprise Value of Zogenix, Inc. over the last ten years is 732.12M. The current 67.30M Enterprise Value has changed 819.19% with respect to the historical average. Over the past ten years (40 quarters), ZGNX's Enterprise Value was at its highest in in the March 2019 quarter at 2.28B. The Enterprise Value was at its lowest in in the June 2016 quarter at 93.26M.
Average
732.12M
Median
565.08M
Minimum
94.40M
Maximum
2.20B
Discovering the peaks and valleys of Zogenix, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 249.86%
Maximum Annual Enterprise Value = 2.20B
Minimum Annual Increase = -51.83%
Minimum Annual Enterprise Value = 94.40M
| Year | Enterprise Value | Change |
|---|---|---|
| 2021 | 939.73M | -11.12% |
| 2020 | 1.06B | -51.83% |
| 2019 | 2.20B | 67.17% |
| 2018 | 1.31B | 64.17% |
| 2017 | 799.90M | 245.26% |
| 2016 | 231.68M | 26.47% |
| 2015 | 183.19M | 3.90% |
| 2014 | 176.32M | -46.61% |
| 2013 | 330.25M | 249.86% |
| 2012 | 94.40M | -0.85% |
The current Enterprise Value of Zogenix, Inc. (ZGNX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.40B
5-year avg
1.26B
10-year avg
732.12M
Zogenix, Inc.’s Enterprise Value is less than CinCor Pharma, Inc. (1.14B), less than EQRx, Inc. (650.25M), less than POINT Biopharma Global Inc. (1.05B), less than VectivBio Holding AG (848.58M), less than CTI BioPharma Corp. (1.22B), less than Albireo Pharma, Inc. (677.78M), less than Verve Therapeutics, Inc. (966.13M), less than Fusion Pharmaceuticals Inc. (1.82B), less than Ambrx Biopharma Inc. (1.73B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.14B | $1.27B | |
| 650.25M | $1.14B | |
| 1.05B | $1.33B | |
| 848.58M | $1.06B | |
| 1.22B | $1.20B | |
| 677.78M | $915.89M | |
| 966.13M | $994.04M | |
| 1.82B | $1.83B | |
| 1.73B | $1.77B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zogenix, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Zogenix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Zogenix, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Zogenix, Inc. (ZGNX)?
What is the 3-year average Enterprise Value for Zogenix, Inc. (ZGNX)?
What is the 5-year average Enterprise Value for Zogenix, Inc. (ZGNX)?
How does the current Enterprise Value for Zogenix, Inc. (ZGNX) compare to its historical average?